Back to Search Start Over

Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models.

Authors :
Sun, Jessica D.
Liu, Qian
Ahluwalia, Dharmendra
Ferraro, Damien J.
Wang, Yan
Jung, Don
Matteucci, Mark D.
Hart, Charles P.
Source :
Cancer Biology & Therapy. 2016, Vol. 17 Issue 4, p371-380. 10p.
Publication Year :
2016

Details

Language :
English
ISSN :
15384047
Volume :
17
Issue :
4
Database :
Academic Search Index
Journal :
Cancer Biology & Therapy
Publication Type :
Academic Journal
Accession number :
114820794
Full Text :
https://doi.org/10.1080/15384047.2016.1139268